Search results
Results From The WOW.Com Content Network
Most commonly, it refers to medication or drug compliance, but it can also apply to other situations such as medical device use, self care, self-directed exercises, or therapy sessions. Both patient and health-care provider affect compliance, and a positive physician-patient relationship is the most important factor in improving compliance. [ 1 ]
A drug-therapy (related) problem can be defined as an event or circumstance involving drug treatment (pharmacotherapy) that interferes with the optimal provision of medical care. In 1990, L.M. Strand and her colleagues (based on the previous work of R.L Mikeal [ 3 ] and D.C Brodie, [ 4 ] published respectively in 1975 and 1980) classified the ...
A prescribing cascade occurs when a person is prescribed a drug and experiences an adverse drug effect that is misinterpreted as a new medical condition, so the patient is prescribed another drug. [21] Polypharmacy also increases the burden of medication taking particularly in older people and is associated with medication non-adherence. [22]
The prevalence of medication nonadherence is high among patients with chronic conditions, such as diabetes, and nonadherence is associated with public health issues and higher health care costs. One reason for nonadherence is the cost of medications.
Lipinski's rule of five, also known as Pfizer's rule of five or simply the rule of five (RO5), is a rule of thumb to evaluate druglikeness or determine if a chemical compound with a certain pharmacological or biological activity has chemical properties and physical properties that would likely make it an orally active drug in humans.
NNT is 1/(0.7 – 0.3), which is 2.5. Effective treatment, but little improvement over control: 0.4: 0.5: 10: Ten receive the treatment, and ten receive a control. In the treatment group six improve with the treatment, and four do not. In the control group, five improve and five do not.
In an experiment with non-compliance, the subjects can be divided into four subgroups: compliers, always-takers, never-takers and defiers. The term d i ( z ) {\displaystyle d_{i}(z)} represents the treatment that subject i {\displaystyle i} actually takes when their treatment assignment is z i {\displaystyle z_{i}} .
Medication therapy management, generally called medicine use review in the United Kingdom, is a service provided typically by pharmacists, medical affairs, and RWE scientists that aims to improve outcomes by helping people to better understand their health conditions and the medications used to manage them. [1]